CHK-IN-1 Catalog No.:M20963-C Acta Neuropathol Commun

Acta Neuropathol Commun

Smiles: CC[C@H](C)[C@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO[C@@]3(C[C@H](O)[C@@H](NC(C)=O)[C@H](C[C@H](O)[C@H](O)CO)O3)C(O)=O)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O

with a mean half-life of 3

3-benzodiazol-2-yl]-6-chloroimidazo[1

CHK-IN-1 Catalog No.:M20963-C Acta Neuropathol CommunCHK IN 1 is an inhibitor of CHK1 and CHK2, with anti proliferative activities. Product information CAS Number: 1278405 51 8 Molecular Weight: 407. 89 Formula: C18H19ClFN5OS Chemical Name: 2 (3 fluorophenyl) 4 {[(3S) piperidin 3 yl]amino}thieno[2,3 d]pyridazine 7 carboxamide hydrochloride Smiles: Cl. NC(=O)C1=NN=C(N[C@@H]2CNCCC2)C2C=C(SC=21)C1C=C(F)C=CC=1 InChiKey: UQMQCIABCNUZPU YDALLXLXSA N InChi: InChI=1S C18H18FN5OS. ClH c19 11 4 1 3 10(7 11)14 8